Literature DB >> 20371280

Effects of mitragynine from Mitragyna speciosa Korth leaves on working memory.

Evhy Apryani1, M Taufik Hidayat, M A A Moklas, S Fakurazi, N Farah Idayu.   

Abstract

AIM OF THE STUDY: Mitragyna speciosa Korth from Rubiaceae family is a tropical plant indigenous to Southeast Asia particularly in Thailand, Peninsular of Malaysia and Indonesia. The leaves have been used by natives for their opium-like effect and cocaine-like stimulant ability to combat fatigue and enhance tolerance to hard work. However there is no scientific information about the effect of mitragynine on the cognitive performances. This study is designed to examine the working memory effects of mitragynine which is extracted from Mitragyna speciosa mature leaves.
MATERIALS AND METHODS: The cognitive effect was studied using object location task and the motor activity in open-field test. Mitragynine 5, 10 and 15 mg/kg and were administered by intraperitoneal (IP) for 28 consecutive days and evaluated on day 28 after the last dose treatment. Scopolamine was used as the control positive drug.
RESULTS: In this study there is prominent effects on horizontal locomotor activity was observed. Mitragynine significantly reduced locomotor activity in open-field test compared with vehicle. In object location task mitragynine (5, 10 and 15 mg/kg) did not showed any significances discrimination between the object that had changed position than the object that had remain in a constant position.
CONCLUSION: Our results suggest that chronic administration of mitragynine can altered the cognitive behavioral function in mice. Crown Copyright 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371280     DOI: 10.1016/j.jep.2010.03.036

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  16 in total

1.  Discriminative stimulus properties of mitragynine (kratom) in rats.

Authors:  Norsyifa Harun; Zurina Hassan; Visweswaran Navaratnam; Sharif M Mansor; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2015-01-25       Impact factor: 4.530

2.  Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism.

Authors:  Jeffery D Foss; Sunil U Nayak; Christopher S Tallarida; Daniel J Farkas; Sara J Ward; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2020-02-27       Impact factor: 4.492

3.  Behavioural and Electrophysiological Evidence of Impaired Learning and Memory in Male Sprague Dawley Rats following Subchronic Exposure to Standardised Methanolic Extract of Mitragyna speciosa Korth.

Authors:  Mohd Ulul Ilmie; Sharif Mahsufi Mansor; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2015-12

4.  Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.

Authors:  Anne-Christin Stolt; Helmut Schröder; Hartmud Neurath; Gisela Grecksch; Volker Höllt; Markus R Meyer; Hans H Maurer; Nancy Ziebolz; Ursula Havemann-Reinecke; Axel Becker
Journal:  Psychopharmacology (Berl)       Date:  2013-07-12       Impact factor: 4.530

5.  Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice.

Authors:  Kai Yue; Jonathan L Katz; Xiji Shu
Journal:  Psychopharmacology (Berl)       Date:  2022-02-02       Impact factor: 4.530

6.  Mitragynine improves cognitive performance in morphine-withdrawn rats.

Authors:  Chiek Yi You; Zurina Hassan; Christian P Müller; Farah Wahida Suhaimi
Journal:  Psychopharmacology (Berl)       Date:  2021-10-25       Impact factor: 4.530

7.  Pharmacokinetics of mitragynine in man.

Authors:  Satariya Trakulsrichai; Korbtham Sathirakul; Saranya Auparakkitanon; Jatupon Krongvorakul; Jetjamnong Sueajai; Nantida Noumjad; Chonlaphat Sukasem; Winai Wananukul
Journal:  Drug Des Devel Ther       Date:  2015-04-29       Impact factor: 4.162

Review 8.  Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom.

Authors:  Dimy Fluyau; Neelambika Revadigar
Journal:  Front Psychiatry       Date:  2017-04-24       Impact factor: 4.157

Review 9.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130

Review 10.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.